第一单位：
Cell Signalling, Cancer Institute, University College London, London, UK.
作者：
Grace Q,Gong [1]
;
Benoit,Bilanges [1]
;
Ben,Allsop [2]
;
Glenn R,Masson [3]
;
Victoria,Roberton [4]
;
Trevor,Askwith [2]
;
Sally,Oxenford [2]
;
Ralitsa R,Madsen [1]
;
Sarah E,Conduit [1]
;
Dom,Bellini [5]
;
Martina,Fitzek [6]
;
Matt,Collier [6]
;
Osman,Najam [7]
;
Zhenhe,He [7]
;
Ben,Wahab [8]
;
Stephen H,McLaughlin [5]
;
A W Edith,Chan [9]
;
Isabella,Feierberg [10]
;
Andrew,Madin [11]
;
Daniele,Morelli [1]
;
Amandeep,Bhamra [12]
;
Vanesa,Vinciauskaite [13]
;
Karen E,Anderson [14]
;
Silvia,Surinova [12]
;
Nikos,Pinotsis [15]
;
Elena,Lopez-Guadamillas [1]
;
Matthew,Wilcox [4]
;
Alice,Hooper [2]
;
Chandni,Patel [2]
;
Maria A,Whitehead [1]
;
Tom D,Bunney [16]
;
Len R,Stephens [14]
;
Phillip T,Hawkins [14]
;
Matilda,Katan [16]
;
Derek M,Yellon [7]
;
Sean M,Davidson [7]
;
David M,Smith [17]
;
James B,Phillips [4]
;
Richard,Angell [18]
;
Roger L,Williams [5]
;
Bart,Vanhaesebroeck [19]
作者单位：
Cell Signalling, Cancer Institute, University College London, London, UK.
[1]
Drug Discovery Group, Translational Research Office, University College London, London, UK.
[2]
Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.;Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK.
[3]
UCL Centre for Nerve Engineering, UCL School of Pharmacy, University College London, London, UK.
[4]
Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
[5]
Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK.
[6]
The Hatter Cardiovascular Institute, University College London, London, UK.
[7]
Medicines Discovery Institute, School of Biosciences, Cardiff University, Cardiff, UK.
[8]
Wolfson Institute for Biomedical Research, University College London, London, UK.
[9]
Molecular AI, Discovery Sciences, R&D, AstraZeneca, Waltham, MA, USA.
[10]
Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
[11]
Proteomics Research Translational Technology Platform, Cancer Institute, University College London, London, UK.
[12]
Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK.
[13]
Signalling Programme, Babraham Institute, Cambridge, UK.
[14]
Institute of Structural and Molecular Biology, Birkbeck College, London, UK.
[15]
Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK.
[16]
Emerging Innovations, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
[17]
Drug Discovery Group, Translational Research Office, University College London, London, UK.;Medicines Discovery Institute, School of Biosciences, Cardiff University, Cardiff, UK.
[18]
Cell Signalling, Cancer Institute, University College London, London, UK. bart.vanh@ucl.ac.uk.
[19]
DOI
10.1038/s41586-023-05972-2
PMID
37225977
发布时间
2025-02-12
换一批
换一批
